Literature DB >> 7107014

Nosocomial bacteremia due to Acinetobacter calcoaceticus.

R Raz, G Alroy, J D Sobel.   

Abstract

In 1980, 13 patients with positive blood cultures for Acinetobacter calcoaceticus were detected in an 800 bed university medical center. Twelve of the 13 isolates were identified as Acinetobacter calcoaceticus var. anitratus and one as var. lwoffi. In the same period there were 361 positive specimens of A. calcoaceticus. Eight of the patients were classified as having significant bacteremia (Group A) with a serious infection in which Acinetobacter was considered a significant pathogen. Five additional patients, however, (Group B) had fever and only one set of positive blood cultures. The significance of these positive isolates was unclear to the attending clinicians. All but one Group A patient appeared to have acquired their infection during hospitalization. In this group, one patient had an underlying pneumonia as the source of bacteremia. In the remaining patients bacteremia was related to some form of invasive catheterization. Seven patients responded rapidly to appropriate antimicrobial therapy and one patient with terminal cancer died as a result of infection. This report reviews the clinical spectrum of Acinetobacter bacteremia, which can range from mild, possibly self-limiting bacteremia to serious, life-threatening septicaemia, especially in compromised hospitalized patients.

Entities:  

Mesh:

Year:  1982        PMID: 7107014     DOI: 10.1007/BF01640769

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  EVALUATION OF THE CLINICAL SIGNIFICANCE OF THE GENUS HERELLEA.

Authors:  R G ROBINSON; R G GARRISON; R W BROWN
Journal:  Ann Intern Med       Date:  1964-01       Impact factor: 25.391

2.  THE HUMAN SKIN AS A SOURCE OF MIMA-HERELLEA INFECTIONS.

Authors:  D TAPLIN; N ZAIAS
Journal:  JAMA       Date:  1963-12-07       Impact factor: 56.272

3.  Infection of man with Mimeae.

Authors:  R C REYNOLDS; L E CLUFF
Journal:  Ann Intern Med       Date:  1963-05       Impact factor: 25.391

4.  Increasing incidence of nosocomial Herellea vaginicola infections in burned patients.

Authors:  C D GRABER; E R RABIN; A D MASON; E H VOGEL
Journal:  Surg Gynecol Obstet       Date:  1962-01

5.  Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern.

Authors:  H F Retailliau; A W Hightower; R E Dixon; J R Allen
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

6.  Sources of pseudomonas and acinetobacter species found in human culture materials.

Authors:  S L Rosenthal
Journal:  Am J Clin Pathol       Date:  1974-12       Impact factor: 2.493

7.  Nonfermentative gram-negative bacilli of nosocomial interest.

Authors:  P Gardner; W B Griffin; M N Swartz; L J Kunz
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

8.  Organisms of the tribe Mimeae: incidence of isolation and clinical correlation at the City of Memphis Hospitals.

Authors:  A P Inclan; L C Massey; B G Crook; J S Bell
Journal:  South Med J       Date:  1965-10       Impact factor: 0.954

Review 9.  Moraxella, Acinetobacter, and the Mimeae.

Authors:  S D Henriksen
Journal:  Bacteriol Rev       Date:  1973-12

10.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

  10 in total
  7 in total

1.  Ciprofloxacin in the treatment of nosocomial multiply resistant Acinetobacter calcoaceticus bacteremia.

Authors:  Y Leonov; F Schlaeffer; J Karpuch; A Bourvin; Y Shemesh; G Lewinson
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

2.  An outbreak of Acinetobacter calcoaceticus infection in a neonatal care unit.

Authors:  R L Schloesser; E A Laufkoetter; T Lehners; C Mietens
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

Review 3.  Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.

Authors:  H Seifert; A Strate; A Schulze; G Pulverer
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

4.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  Discrimination of epidemic and sporadic isolates of Acinetobacter baumannii by repetitive element PCR-mediated DNA fingerprinting.

Authors:  A C Reboli; E D Houston; J S Monteforte; C A Wood; R J Hamill
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

6.  Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains.

Authors:  J Vila; M Almela; M T Jimenez de Anta
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

7.  Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.

Authors:  Tan N Doan; David C M Kong; Caroline Marshall; Carl M J Kirkpatrick; Emma S McBryde
Journal:  Virulence       Date:  2015-08-07       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.